Tag: epithelial ovarian cancer (EOC)

HIPEC_650x450

April 23, 2021/Cancer

Hyperthermic Intraperitoneal Chemotherapy with Cisplatin and Paclitaxel Improves Progression-Free Survival Compared with Cisplatin Alone

Combination improves outcomes without increasing postoperative morbidity

20-WHI-1984960_CQD_650x450_1242485859

December 21, 2020/Ob/Gyn & Women’s Health/Gynecologic Oncology

Research Finds Antibiotic Use During Chemotherapy Is Associated With Decreased Overall Survival in Women With Epithelial Ovarian Cancer

Caution warranted when prescribing antibiotics to these patients

Study Examines Factors Associated with Non-Completion of Intraperitoneal with Intravenous Chemotherapy in Women with Epithelial Ovarian Cancer

December 5, 2019/Cancer

Factors Associated with Non-Completion of IP/IV Chemotherapy in Women with Epithelial Ovarian Cancer

Non-home discharge and higher ECOG status associated with IP/IV chemotherapy non-completion

BackPage 1 of 1Next

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Ad